Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies
Citation
Alvi , M A , Loughrey , M B , Dunne , P , McQuaid , S , Turkington , R , Fuchs , M-A , McGready , C , Bingham , V , Pang , B , Moore , W , Maxwell , P , Lawler , M , James , J A , Murray , G I , Wilson , R H & Salto-Tellez , M 2017 , ' Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies ' , British Journal of Cancer , vol. 117 , no. 2 , pp. 203-209 . https://doi.org/10.1038/bjc.2017.168
Rights
This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/